Esketamine: A Possible Adjunctive Therapy for Treatment Resistant Depression.
Journal of the American Board of Family Medicine : JABFM January 1, 2025 Annie Huang, Jennifer L Fernandez Vasquez, Catherine A Yeager
For people with treatment-resistant depression, adding esketamine to their current medication leads to higher rates of remission than adding quetiapine, according to the text.